1- Livermore, D. M. (1995). β-lactamase in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
2- Coudron, P.E., Moland, E.S., and Thomson,K.S. (2000). Occurrence and detection of AmpC β-lactamase among Esherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol. 38:1791-1796.
3- Moland, E.S., Black, J.A., Ourda, J., Reisbig, M.D., Hanson, N.D., and Thomson, K.S. (2002). Occurrence of newer ß-lactamase in Klebsiella pneumnoiae isolates from 24 U.S hospital. Antimicrob. Agents Chemother. 46:3837-3842.
4- Black, J.K., Moland, E. S., and Thomson, K.S. (2005). AmpC Disk Test for Detection of Plasmid-Mediated AmpC ß-Lactamases in Enterobacteriaceae Lacking Chromosomal AmpC β-Lactamases. J of Clin Microbiol .43 (7): 3110-3113.
5- Fridkin, S.K., Welbel, S.F., and Weinstein, R.A. (1997). Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am. 1997; 11:479-496.
6- Medeiros AA. (1997) Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis. 24 (Suppl 1): S19-45.
7- Kaye, K.S., Fraimow, H.S., and Abrutyn, E. (2000). pathogens resistant to antimicrobial agents Epidemiology, Molecular Mechanisms, and Clinical Management. Infect Dis Clin of North America. 14(2): 293-319.
8. Schwaber, M.J., Graham, C.S., Sand, S.B.E., Gold, H.S., and Carmeli, Y. (2003). Treatment with a broad–spectrum cephalosporin versus piperacillin-resistant Enterobacter species. Antimicrob Agents and Chemother. 1882-1886.
9- Pitout, J.D.D., Gergson, D.B., Church, D.L., and Lapland, K.B. (2007). Population-based Laboratory Surveillance for AmpC β-Lactamase–producing Escherichia coli,Calgary. Emerg Infect Dis.13 (3).
10- Nasim, K., Elsayed, E., Pitout, J.D.P., Conly, J., Church, D.L., and Gregson, D.B. (2004). New method for laboratory detection of AmpC β-lactamase in Esherichia coli and Klebsiella pneumoniae. J of Clin microbial. 42(10): 4799-4802.
11- Thomson, K.S. (2001). Controversies about extended-spectrum and AmpC β-Lactamase.CDC. 7:333-336.
12- Soussy, C.J., Carret, G., Cavallo, J.D., Chardon, H., Chidiac, C., Choutet, P., Courvalin, P., Dabernat, H., Drugeon, H., Dubreuil, L., Goldstein, F., Jarlier, V., Leclercq, R., Nicolas-Chanoine, M.H., Philippon, A., Quentin, C., Rouveix, B., and Sirot., J. (2001). Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué. Pathol. Biol. 48:832-871.
13- Brown, R. and Poxton, I,R.(1996). Centrifuges, colorimeters and bacterial counts. In: Mackie and McCartney Practical Medical Microbiology. (eds Collee, J. G., Fraser, A.G., Marmion, B.P and Simmons, A.. P845-852. 14th ed. Churchill Livingstone, Singapore.
14- Bouza, E. and Cerenado, E. (2002). Klebseilla and Enterobacter: antibiotic resistance and treatment implications. Semin Respir Infect. 17(3): 215-230.
15- Kolar, M., Bardon, J.,Chroma, M.,Hricova, K.,Stosoval,T., Sauer,P., and Koukalova ,D.(2010). ESBL and AmpC beta-lactamase-producing Enterobacteriaceae in poultry in the Czech Republic. Veterinarni Medicina, 55 (3): 119–124
16- Livermore, D. M. (1998). β-lactamase-mediated resistance and opportunities for its control. J. of Antimicrob. Chemother. 41:25-41.
17- Nigel, P., Jevons, B.G., Andrews, A., Ang, L., and Fraise, A.P. (2005). Disc methods for detecting AmpC ß-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae. J. of Antimicrob. Chemother . 56(3):600-601.
18- Yagi, T., Wachino, J., Kurokawa, H., Suzuki, S., Yamane, K., Doi, Y., Shibata, N., Kato, H., Shibayama, K. and Arakawa, Y. (2005). Practical methods using boronic acid compounds for identification of class C β-lactamase producing Klebsiella pneumoniae and Escherichia coli. J of Clin Microbial. 43(6): 2551-2558.